Bioelectronics Corp (BIEL)

[kidnova]

I can almost assure you that a large portion, if not all, of the dilution that has occurred this quarter was due to debt coversion at a rate of $.0012/share, or $61,800 in debt paid off. It was then sold into the market at prices between $.005 to $.01 for a hefty profit.

They should be posting the Q3 financial statements sometime in the next two weeks, so you'll know for sure how much dilution was due to debt conversion between 6/1 and 9/30, but I think you're going to see very little of it was used to raise cash for the company, IMO.